Skip to main content

and
  1. No Access

    Article

    c-CBL is not required for leukemia induction by Bcr-Abl in mice

    Bcr-Abl tyrosine kinase activity is essential for the pathogenesis of chronic myeloid leukemia (CML). A number of Bcr-Abl substrates have been identified, but it is not clear which of these substrates are require...

    Daniela M Dinulescu, Lisa J Wood, Lei Shen, Marc Loriaux, Christopher L Corless in Oncogene (2003)

  2. No Access

    Article

    Gastrointestinal stromal tumors (GISTs) with KIT and PDGFRA mutations have distinct gene expression profiles

    Most GISTs require oncogenic activation of the KIT or PDGFRA receptor tyrosine kinase proteins, and the genomic mechanisms of oncogene activation are heterogeneous. Notably, the kinase mutation type correlates wi...

    Subbaya Subramanian, Robert B West, Christopher L Corless, Wenbin Ou in Oncogene (2004)

  3. Article

    Open Access

    Characterizing advanced breast cancer heterogeneity and treatment resistance through serial biopsies and comprehensive analytics

    Molecular heterogeneity in metastatic breast cancer presents multiple clinical challenges in accurately characterizing and treating the disease. Current diagnostic approaches offer limited ability to assess he...

    Allen Li, Jamie M. Keck, Swapnil Parmar, Janice Patterson in npj Precision Oncology (2021)

  4. Article

    Open Access

    Multiomics analysis of serial PARP inhibitor treated metastatic TNBC inform on rational combination therapies

    In a pilot study, we evaluated the feasibility of real-time deep analysis of serial tumor samples from triple negative breast cancer patients to identify mechanisms of resistance and treatment opportunities as...

    Marilyne Labrie, Allen Li, Allison Creason, Courtney Betts in npj Precision Oncology (2021)